Cardiovascular

Latest News

Christian Ruff, MD
Abelacimab Shows Potential to Shift the Standard of Care in AFib

February 11th 2025

Results from the AZALEA-TIMI 71 phase 2 trial showed great promise for abelacimab to transform care for high-risk patients with atrial fibrillation.

Christian Ruff, MD
Dr Ruff Explores Mitigating Surgical Bleeding in AFib With Abelacimab

February 6th 2025

Conceptualizing reduced cost and increased value | image credit: patpitchaya - stock.adobe.com
Polypill Treatment: A Clinically Effective and Cost-Saving Strategy for CVD Management

February 3rd 2025

FDA approval | image credit: Aquir - stock.adobe.com
FDA Expands Semaglutide Use for CV, Kidney Risks in T2D, CKD

January 28th 2025

Glass of sugar cubes | Image Credit: © grzejnik1981-stock.adobe.com
Curbing Sugary Beverages for Health and Economic Gains

January 28th 2025

Advancements in Population Health Strategies for Cardiovascular Risk Management

Experts discuss how lipoproteins drive atherosclerotic heart disease, review the different guidelines and recommendations on Lp(a) testing, and insights from clinical trials.

Hands holding a heart with a heartbeat on it and the words AJMC Insights

More News

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo